SLIT3 Protein Activates Brown Fat Through Vessel and Nerve Expansion, Offering New Obesity Strategy
Researchers have identified a mechanism by which the protein SLIT3 activates brown fat through the expansion of its blood vessels and nerves. This discovery, published in Nature Communications, suggests a potential new strategy for treating obesity that differs from current appetite-suppressing approaches.
Understanding Brown Fat
Brown fat is a specialized tissue found in humans and other mammals known for generating heat, a process called thermogenesis. It is associated with weight loss and metabolic health. Unlike white fat, which stores excess energy, brown fat utilizes resources such as glucose and lipids to produce heat when activated, for instance, by cold. This process consumes fuel sources, preventing them from being stored as white fat.
The function of brown fat relies on dense networks of nerves and blood vessels. Nerves facilitate communication with the brain for activation signals, while blood vessels supply oxygen and nutrients required for heat generation and distribute heat throughout the body.
Brown fat's crucial function depends on dense networks of nerves and blood vessels, which supply vital signals, oxygen, and nutrients for heat generation. Prior research had less understanding of these underlying support networks, primarily focusing on directly stimulating fat cells.
The SLIT3 Protein: A 'Split Signal' Mechanism
Farnaz Shamsi's lab at NYU College of Dentistry identified SLIT3 as a protein secreted by brown fat cells. Dr. Shamsi is an assistant professor of molecular pathobiology and a senior author of the study. The research found that the enzyme BMP1 cleaves SLIT3 into two distinct fragments. These two fragments regulate different processes: one promotes the growth of blood vessels, and the other expands nerve networks. This coordinated regulation of both components is described as a 'split signal' mechanism.
Further investigation identified the PLXNA1 receptor, which binds to one of the SLIT3 fragments to specifically control brown fat's nerve network. Studies conducted in mice demonstrated that removing SLIT3 or the PLXNA1 receptor impaired brown fat's proper nerve structure and blood vessel density. This impairment resulted in the mice experiencing cold sensitivity and difficulty in maintaining their body temperature.
Implications for Human Health and Therapeutic Avenues
An examination of fat tissue samples from over 15,000 individuals, including those with obesity, indicated that SLIT3 gene expression may regulate fat tissue health, inflammation, and insulin sensitivity in humans. This suggests the pathway's relevance to human obesity and metabolic health.
While many existing weight loss medications, such as GLP-1s, primarily function by suppressing appetite, treatments targeting brown fat have the potential to increase energy expenditure.
The detailed understanding of SLIT3's role in controlling brown fat's infrastructure – specifically how it undergoes cleavage and binds to receptors to develop nerve and blood vessel networks – highlights several processes that could be targeted for therapeutic interventions aimed at enhancing brown fat's heat production capacity and metabolic benefits.